Ecstasy (MDMA) floods your brain with three chemical messengers at once: serotonin, dopamine, and norepinephrine. The surge of serotonin is the main driver of the drug’s signature effects, producing intense euphoria, emotional closeness, and heightened sensitivity to touch. Effects typically last 3 to 6 hours, but the drug takes roughly 40 hours to fully clear your body, which helps explain why aftereffects can linger for a day or two.
How It Works in the Brain
MDMA belongs to the amphetamine family, but it behaves differently from classic stimulants like speed or cocaine. While those drugs primarily boost dopamine, MDMA’s strongest action is on serotonin, the chemical that regulates mood, emotional bonding, sleep, and appetite. The drug hijacks the transporters that normally recycle serotonin back into nerve cells, reversing their direction so they pump serotonin out instead. The result is a massive spike in serotonin activity across the brain.
Dopamine and norepinephrine get a boost too, though to a lesser degree. Dopamine contributes to the energizing, pleasurable rush, while norepinephrine drives the physical stimulant effects like a faster heart rate and rising blood pressure. MDMA also triggers the release of acetylcholine in parts of the brain involved in memory and attention, which may contribute to the altered sense of awareness users describe.
What the High Feels Like
MDMA is absorbed through the gut and reaches peak blood levels about 2 hours after swallowing a pill. Users typically take one to two tablets, each containing between 60 and 120 milligrams. The experience combines stimulant energy with mild psychedelic shifts in perception.
The most commonly reported effects include:
- Euphoria and emotional warmth: a powerful sense of well-being, closeness to others, and empathy
- Heightened senses: touch feels more intense, music sounds richer, and lights appear more vivid
- Reduced inhibition: social anxiety drops and conversation feels effortless
- Distorted sense of time: minutes can feel stretched or compressed
- Increased energy: a desire to move, dance, or be physically active
These effects are why MDMA became associated with dance music culture. The combination of energy, sensory enhancement, and emotional openness creates an experience people describe as profoundly connecting.
Physical Effects on the Body
Along with the psychological high, MDMA puts real physiological stress on your body. Heart rate and blood pressure climb. Body temperature rises, partly because the drug increases heat production while making it harder for your body to cool down. In hot, crowded environments like clubs or festivals, this impaired temperature regulation becomes genuinely dangerous.
Other common physical effects include jaw clenching (bruxism), teeth grinding, nausea, headache, dry mouth, and agitation. The jaw clenching can be intense enough that many users chew gum or use mouth guards to prevent tooth damage. Pupils dilate noticeably, and some people experience blurred vision or rapid eye movements.
The Comedown
Because MDMA forces your brain to dump its serotonin reserves all at once, the days after use often involve a noticeable emotional dip. This “comedown” can start within 24 hours and typically resolves over 3 to 5 days. Common symptoms include low mood, irritability, anxiety, poor sleep, reduced appetite, and difficulty concentrating.
The comedown happens even after a single use. It’s distinct from withdrawal (which develops after repeated, long-term use), though the symptoms overlap considerably. The severity tends to scale with dose: the higher the dose and the more serotonin depleted, the rougher the days that follow. Many regular users describe Tuesdays after weekend use as the lowest point, sometimes calling it “Suicide Tuesday,” though actual suicidal behavior from a single-use comedown is rare.
Serious Acute Risks
Most MDMA-related emergencies trace back to two problems: overheating and dangerously low sodium levels.
Hyperthermia, or a spike in body temperature, is the most well-documented acute danger. In dance settings where people are physically active, sweating heavily, and not cooling down, core temperature can climb to life-threatening levels. This can trigger a cascade of organ damage including muscle breakdown, liver failure, abnormal blood clotting, and heart problems.
The second major risk, hyponatremia, happens when sodium levels in the blood drop too low. MDMA stimulates the release of a hormone that causes the body to retain water. Combine that with excessive water drinking (often from users who’ve heard they should “stay hydrated”) and sodium lost through sweat, and the blood becomes dangerously diluted. Symptoms progress from confusion and nausea to seizures, brain swelling, and in severe cases, death. Women appear to be at higher risk for this complication. In documented fatal cases, most involved female users, and all four reported deaths from MDMA-induced hyponatremia involved brain swelling.
What Street Ecstasy Actually Contains
One of the less obvious risks of ecstasy is that the pill you take may not contain MDMA at all, or may contain MDMA mixed with other drugs. Testing data spanning over two decades in the United States paints a concerning picture. In analyses from 2009 to 2013, only 11 to 35 percent of samples sold as ecstasy contained MDMA alone in any given year. The most common adulterants have shifted over time: dextromethorphan (a cough suppressant) dominated in the early 2000s, caffeine became the top contaminant in the mid-2000s, and synthetic piperazines (chemicals marketed as legal MDMA alternatives) appeared frequently in the early 2010s. Even in the earliest testing data from 1999 to 2000, only 63 percent of samples contained MDMA or a close chemical relative.
This means the effects someone experiences from a street ecstasy pill may not reflect MDMA at all. They could be taking stimulants, dissociatives, or combinations that carry their own unpredictable risks.
Long-Term Effects on the Brain
Animal research has consistently shown that MDMA damages serotonin-producing nerve cells. In rats given moderate to high doses, serotonin levels in key brain regions (the cortex and hippocampus) dropped by 25 to 74 percent and remained suppressed for at least 32 weeks, the longest time point measured. The number of serotonin transporter sites, a marker of healthy serotonin nerve terminals, declined by a similar amount over the same period.
Perhaps more concerning, the brain didn’t compensate. You might expect the remaining serotonin neurons to ramp up production to make up for the loss, but that didn’t happen. The rate of serotonin synthesis in surviving nerve terminals stayed essentially the same as in undamaged brains. The enzyme needed to make serotonin did recover its activity by 32 weeks, but overall serotonin output remained low because there were simply fewer functioning terminals.
Translating animal findings directly to humans is imperfect, since the doses used in lab studies are often higher than typical recreational doses. But brain imaging studies in human ecstasy users have shown reduced serotonin transporter density, and heavy users frequently report lasting problems with memory, mood regulation, and sleep, all functions that depend on healthy serotonin signaling.
MDMA in Therapeutic Research
The same properties that make MDMA appealing recreationally, emotional openness, reduced fear, and increased trust, have drawn interest from researchers studying PTSD. The idea is that MDMA, given in a controlled clinical setting alongside therapy sessions, could help people process traumatic memories they’d normally avoid.
MDMA received Breakthrough Therapy Designation from the FDA in 2017 for PTSD treatment, and two Phase 3 clinical trials (involving a combined 195 participants with moderate to severe PTSD) were completed by late 2022. The manufacturer, Lykos Therapeutics, submitted a formal application for approval in December 2023. However, the FDA has raised concerns about the data, and approval is not guaranteed. If it were approved, it would come with significant restrictions: patients would take the drug only a limited number of times under direct clinical supervision, and ongoing safety monitoring including liver function tests would likely be required.